April 28, 2026
Successfully Holds Extraordinary General Meeting of Shareholders, Phapros (PEHA) Appoints Intan Abdams Katoppo as New Captain
JAKARTA, April 28, 2026 – PT Phapros Tbk (PEHA), a leading pharmaceutical company in Indonesia, successfully held an Extraordinary General Meeting of Shareholders (EGMS/RUPS-LB) in Jakarta on Monday, April 27, 2026....
See More
April 21, 2026
Continuing the Success of 2025, Phapros (PEHA) Successfully Records Net Profit Growth of 113% in Quarter 1/2026
In the first three months of 2026, Phapros once again posted significant net profit growth reaching 112.86% y-o-y....
See More
April 08, 2026
High Commitment to Performance and Sustainability, Phapros (PEHA) Wins Green PROPER Award Again
This commitment is realized through 5 successful flagship programs: energy and water efficiency, reduction of hazardous and toxic waste (B3) and non-hazardous waste (non-B3), and management of non-B3 waste through 3R (reduce, reuse, and recycle)....
See More
April 01, 2026
Phapros Records Net Profit Growth of Up to 109% in 2025, Driven by Significant Sales Increase & Production Cost Efficiency
The issuer with the stock code PEHA successfully recorded a net profit of Rp27.44 billion from January to December 2025, an increase of 109% compared to the same period the previous year, which still recorded a loss of Rp290.63 billion. ...
See More
March 19, 2026
Phapros Accompanies Homebound Travelers,Strengthens Role as the Community's "Sahabat Sehat"
PT Phapros Tbk (PEHA) reaffirms its commitment to supporting public health through the "Phapros Sahabat Sehat" ...
See More
December 20, 2025
Phapros Introduces New Product for Adult Men's Health at INASAU 2025
PT Phapros Tbk (PEHA) reaffirms its commitment to supporting the improvement of men's health quality through its participation and support at The 4th InaSAU Meeting...
See More